Bone metabolic markers in bone metastasis of breast cancer


Background. The efficacy and cost-performance benefit of radionuclide bone scintigraphy in monitoring metastatic bone activity remain controversial. Bone metabolic markers are now expected to play a role in the diagnosis and follow-up of bone metastasis. Methods. We investigated several bone metabolic markers in patients with breast cancer. We measured… (More)
DOI: 10.1007/s101470050080


7 Figures and Tables

Cite this paper

@article{Koizumi1999BoneMM, title={Bone metabolic markers in bone metastasis of breast cancer}, author={Masahiko Koizumi and Syugen Takahashi and Etsuro Ogata}, journal={International Journal of Clinical Oncology}, year={1999}, volume={4}, pages={331-337} }